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Abstract
Background: Annual immunization is the most effective way to prevent influenza and its associated complications.
However, optimal immunization rates are not being met in Nova Scotia, Canada. Additional providers, such as
pharmacists, may improve access and convenience to receive vaccines. Pharmacists began immunizing patients
5 years of age and older within the publicly funded universal influenza vaccination program during the 2013-2014
influenza season. The objective of this study was to evaluate influenza immunization coverage rates before and
after pharmacists in Nova Scotia gained authority to immunize as part of the publicly funded universal influenza
vaccination program.
Methods: Influenza immunization data was obtained from the Department of Health and Wellness from 2010 to
2015. Data included billing data from physicians and pharmacists, and local public health data. Vaccination
coverage was calculated as proportion of vaccinations received in comparison to the total population.
Results: Prior to pharmacists immunizing, overall vaccination coverage for Nova Scotia residents 6 months of age
and older was 35.8 % in 2012-2013, increasing to 41.8 % coverage in 2013-2014 the year pharmacists began
immunizing. A decrease of 1.9 to 39.9 % was observed in 2014-2015. In patients 65 years of age and older living in
the community, coverage has increased from 61.8 % in 2012-2013 to 71.6 % in 2013-2014, and again to 73.3 % in
2014-2015 with the addition of pharmacists immunizing. Prior to pharmacists immunizing the highest coverage
noted for this portion of the population was 61.8 %.
Conclusions: The addition of pharmacists as immunizers within a publicly funded universal influenza vaccination
program was found to increase overall vaccination coverage in the first year and to maintain higher coverage rates
in the second year than those observed before pharmacists began immunizing. Increases in coverage in both years
were observed in the elderly. Future research will be required to determine the ongoing impact of the addition of
pharmacists as immunizers and other strategies to improve vaccination coverage.
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Background
Receiving the seasonal influenza vaccine each year is the
most effective way for an individual to protect themselves
from influenza [1, 2]. Globally, influenza rates are esti-
mated between 5 to 10 % for adults and 20 to 30 % among
children. Worldwide, this translates to an approximate
three to five million cases of severe influenza per year,
with an estimated 250,000 to 500,000 deaths attributed to
influenza [3]. Influenza is of greatest concern to those
who are at high risk of complications, such as the elderly,
pregnant women, or those with co-morbidities [1, 4].
Annual influenza immunization is the most effective
way to reduce the risk of influenza-related complica-
tions. As such, several jurisdictions have identified goals
for vaccine coverage rates [5–7], for example, the Office
of Disease Prevention and Health Promotion in the
United States has set annual influenza vaccine targets at
80 % for noninstitutionalized individuals aged 18 to
64 years, and 90 % for anyone aged 18 years and older
who is institutionalized and for health care personnel
[6]. In Canada, the National Advisory Committee on
Immunization (NACI) has set vaccine coverage goals of
80 % for people 65 years of age or older, those younger
than 65 years of age with high risk comorbidities, and
health care workers; 95 % for residents of long term
care; and 100 % coverage for vaccinators [7]. There are
many challenges to reaching these goals, including ac-
cessibility and convenience of obtaining vaccinations. In
Canada, pharmacists are viewed as highly trusted health
care providers with the potential to decrease these bar-
riers and improve vaccination coverage [8, 9]. In 2013,
legislation was introduced in Nova Scotia (NS), Canada
that allowed pharmacists, with appropriate certification,
the authority to immunize adults and children 5 years of
age and older [8]. Currently, pharmacists are able to ad-
minister the influenza vaccine in 9 of 10 provinces in
Canada [10]. In 2013-2014, pharmacists in NS were able
to provide influenza vaccines as part of the publicly
funded universal vaccination program, which had been
implemented in 2010 [11]. Although data from the
United States, where pharmacists have been providing
immunization services since 1995, demonstrate in-
creased uptake of influenza immunization with the
addition of pharmacist immunizers, little is known about
the impact of pharmacist immunizers in Canada [12–15].
In British Columbia, pharmacy vaccination clinics were
introduced and immunization rates in older people in-
creased [13]. Our evaluation of the first year that pharma-
cists provided immunization services within the publicly
funded universal influenza program showed an increase in
overall vaccination rates, despite a decrease in vaccina-
tions administered by physicians and public health [12].
This study expands on the previous NS data and com-
pares NS influenza immunization rates prior to the addition
of pharmacists as immunizers, with the 2 years following
introduction of immunization services by pharmacists
within the publicly funded universal influenza vaccination
program [12].
Aim of the study
The aim of this study was to compare estimated influ-
enza vaccination coverage in Nova Scotia, Canada in the
3 years prior to the expansion of pharmacist scope of
practice to include administration of vaccinations with
the 2 years in which pharmacists were permitted to
administer influenza vaccines.
Methods
Census data and aggregate immunization data, which
included physician and pharmacist billings and local
public health data, were obtained from the Nova Scotia
Department of Health and Wellness (DHW). Data was
provided as number of vaccinations per district in the
health authority by each type of care provider—physi-
cians, pharmacists and public health/other (which in-
cluded occupational health employees and home care
nurses), and by year (end-August one year, to end-
August the following year). For the purposes of compari-
son 2010-2011, 2011-2012 and 2012-2013 were defined
as the pre-pharmacist involvement influenza seasons;
2013-2014 and 2014-2015 were considered the post-
pharmacist involvement seasons. Vaccination coverage
by provider was defined as the percentage of Nova
Scotia residents vaccinated by each provider type, in re-
lation to the entire population of Nova Scotia. Although
pharmacists can only provide immunizations to those
5 years of age and older, data for those 6 months and
older was used when comparing coverage between pro-
viders due to missing age related data necessary for
alternate comparisons.
Data analysis
Estimated vaccination coverage and 95 % confidence in-
tervals for influenza immunization were constructed for
each year using the number of influenza immunizations
administered as the numerator, and the census data
most proximal to the year of interest as the denominator
(2010-2011and 2011-2012 used 2006 census data; 2012-
2013 and 2013-2014 used 2011 census data and 2014-
2015 used 2013 census data). Coverage was calculated
using total populations and estimates grouped by age
and sex, and compared between vaccination provider
groups. Comparisons between the proportions of the
immunized populations each year were made using Chi-
Square with Bonferronni correction for multiple com-
parisons. All data analysis was completed using EXCEL
XLSTAT version 2015.
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Results
In 2013-2014, 430 pharmacists in NS were licensed to
immunize, and in 2014-2015, 293 additional pharmacists
were licensed to vaccinate, bringing the total to 723.
In 2014-2015, overall vaccination coverage for all Nova
Scotia residents 6 months of age or older decreased by
1.9 % (95 % CI, 1.76–2.04) from 41.8 % (95 % CI, 41.68–
41.88) in 2013-2014 to 39.9 % (95 % CI, 39.78–39.98)
(Fig. 1). The highest vaccination coverage achieved before
pharmacists began immunizing was 38 % (95 % CI, 37.93–
38.13) in 2010-2011. In 2011-2012 and 2012-2013 vaccin-
ation coverage was between 35 % and 36 %. Comparison
of immunization rates by gender did not show any differ-
ences between years, with a ratio of approximately 55 % of
vaccine recipients being female and 45 % being male.
The vaccination coverage provided by pharmacists in-
creased between 2013-2014 and 2014-2015 from 8.4 to
10.2 % (Fig. 2). The vaccination coverage provided by phy-
sicians to patients 6 months of age or older decreased
from 27.2 % in 2013-2014 to 24.5 % in 2014-2015 (Fig. 2).
Likewise, the coverage provided by public health also
decreased from 6.2 to 5.2 % between 2013-2014 and
2014-2015 (Fig. 2).
For individuals 65 years of age and older, overall vaccin-
ation coverage increased by 9.8 % (95 % CI, 9.5–10.2) to
71.6 % (95 % CI, 71.4–71.8) in the first year that pharma-
cists began immunizing, and increased by another 1.7 %
(95 % CI, 1.4–2.0) in the second year, resulting in overall
coverage of 73.3 % (95 % CI, 73.1–73.5) in 2014-2015
(Fig. 3). Physicians remained the primary providers of im-
munizations in this age group (Fig. 3). Prior to pharmacists
immunizing, overall coverage rates in this population were
61.8 % (95 % CI, 61.5–62.0) in 2012-2013. The data were
unavailable for years prior to 2012. A decrease in
immunization coverage was noted for children 6 to
59 months from 45.4 % coverage in 2013-2014 to 40.6 % in
2014-2015, an age group that pharmacists are not permit-
ted to immunize.
The vaccination coverage provided by pharmacists to
the age groups 18–23 years and 24–64 years remained
relatively unchanged from the 2013-2014 influenza vac-
cination season to the 2014-2015 season. There was a
decrease in the coverage provided to 5–17 year olds
compared to 2013-2014 data (12.5 to 9.9 %), whereas
there was an increase in the coverage provided to those
65 years and older (27.4 to 33.1 %).
Discussion
Our data demonstrate that the increase observed in influ-
enza immunization rates immediately following imple-
mentation of pharmacist-provided immunization services
within the universal influenza program was sustained
in the second year of the program. Although a 1.9 %
(95 % CI, 1.76–2.04) reduction in overall rates was ob-
served between the first and second year of pharmacists in
the immunizer role, immunization rates remained higher
than those observed prior to the introduction of pharma-
cist immunizers in NS. Of note, immunization coverage
declined in 2014-2015 in those 6 to 59 months of age,
whom pharmacists are not permitted to immunize, and
therefore contributed to the overall decline in rates, inde-
pendent of pharmacists’ ability to immunize. Furthermore,
immunization rates continued to increase among those
65 years of age and older, an age group that pharmacists
are permitted to immunize.
Limitations of this study include potential errors re-
lated to secondary use of health claims aggregate data,
such as errors in age-related coding, gender coding or
Fig. 1 Number of vaccinations administered and vaccination coverage by year and provider type represented as coverage of total population (%)
for Nova Scotia residents 6 months of age or older
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improper reporting and billing. Missing age related data
in 2012-2013 prevented complete comparisons for the
age range that pharmacists can provide immunizations
(5 years of age and older). In assessing vaccinations for pa-
tients less than 9 years of age, it is not possible to assess
the proportion of patients who received two doses of in-
fluenza vaccine as recommended in the first year vacci-
nated against influenza, an important consideration given
the lack of efficacy of a single dose in this group [11].
However, over-reporting should be consistent in all years
evaluated and by all providers. In addition, the number of
children between 5 and 9 years of age who were immu-
nized by pharmacists was small; therefore the overall im-
pact on results would be expected to be minimal. Other
potential confounders that may have resulted in an in-
crease or decrease in coverage over the years studied in-
clude the 2009 H1N1 pandemic and potential residual
effects on coverage in 2010-2011, and a perceived vaccine
shortage in 2013-2014 related to a distribution delay
[16, 17]. Decreased public confidence due to widespread
media coverage regarding poor vaccine effectiveness sec-
ondary to a mismatch with the predominant circulating
Fig. 2 Trends in influenza vaccination coverage by provider type for patients 6 months of age or older
Fig. 3 Vaccination coverage by provider group and total population coverage for Nova Scotia residents 65 years of age and older, excluding
those in long term care
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strain in 2014-2015 is an additional confounder, which may
have resulted in decreased vaccine uptake that year [11].
Higher rates for vaccination coverage noted in 2010-
2011 may have been associated with the first year of the
universally funded influenza vaccination program, or the
residual impact of the pandemic H1N1 seen in 2009-
2010 [16]. There is no apparent reason why coverage de-
creased from 2011 to 2013. The highest vaccine coverage
in the years studied was observed in the 2 years that in-
cluded pharmacist involvement in the program with the
first year being the highest, possibly in part due to add-
itional advertisements from pharmacies and increased
media attention and news reports on the addition of
pharmacists to the influenza vaccination campaign in
the province. The slight decrease in vaccination coverage
observed in 2014-2015 could be related to the reduced
vaccine effectiveness observed in the 2013-2014 season
during which the vaccine match to the dominant circu-
lating H3N2 strain was poor [18].
These data lend further support to the benefit of
pharmacist involvement in influenza vaccination programs
in Canada or countries with similar health systems. Data
from 2013-2014, the first year that pharmacists provided
immunization services in NS, demonstrated an overall in-
crease in vaccination coverage with the addition of phar-
macists as immunizers and not merely a shift, although
there is some, of vaccinations from other providers to
pharmacists [12]. This is consistent with data from the
United States that showed the benefit of pharmacists in
increasing overall influenza immunization rates, which
showed that those over 18 years of age were more likely to
become vaccinated when the vaccine was provided at their
community pharmacy [14].
With respect to NS data, a steady decline in the number
of vaccinations provided by physicians each year was ob-
served, leading to the question of whether immunization
services previously provided by physicians are now being
substituted by pharmacists. Arguing against this is that
the rate of decline began prior to pharmacists providing
influenza vaccination (Fig. 2). The reasons for the decrease
in the proportion of vaccinations administered by physi-
cians are likely complex, involving both practitioner and
patient factors. Possible explanations include increased re-
sponsibility for physicians, leading to time constraints and
longer wait times for each patient, and shorter patient-
physician interactions resulting in less time to provide im-
munizations [19, 20]. In NS and other parts of Canada,
perceived shortages and concerns around distribution of
family physicians may be a barrier to patient access, which
could directly lead to fewer vaccinations administered by
physicians [21, 22].
Vaccination coverage by public health, while varying from
year to year, has remained relatively steady between 5 and
8 % annually. The decrease in vaccinations administered by
public health in 2013-2014 and 2014-2015 was expected
because fewer public health clinics were offered as a con-
scious effort to allow public health practitioners to focus on
other activities since pharmacists were authorized to also
provide influenza vaccination.
By the end of the second year of pharmacist-provided
immunization, there was an increase in coverage from
71.6 to 73.3 % in those individuals greater than 65 years
of age, approaching the national goal of 80 % coverage
for community dwelling seniors [2]. The overall increase
in coverage in this population was not observed across
all immunization provider groups. While pharmacists
and public health saw an increase in the number of
elderly being vaccinated, the number of older adults im-
munized by physicians continued to decline. Between
2013-2014 and 2014-2015, the demographics of the
population being vaccinated by pharmacists changed,
with an increase in the proportion being administered to
the elderly, and a decreasing proportion being adminis-
tered to all other age groups. This could indicate that
people 65 years of age and older are an important demo-
graphic for pharmacists to engage or that this age group
is most readily accessed by pharmacists. In general, older
adults visit their pharmacy more frequently than youn-
ger people because they have more chronic conditions,
providing more opportunity for pharmacists to make
vaccination recommendations to this population [23]. As
elderly are also at higher risk of complications, pharma-
cists may make greater effort to ensure vaccination in
this population than in younger people presenting to
their pharmacy. It may also relate to the confidence that
older individuals have in pharmacists such that they are
more willing to be vaccinated by a pharmacist than
younger individuals. Our findings are consistent with
both US and Canadian data that also observed patients
65 years of age and older were more likely to become
immunized with the addition of pharmacists as immuni-
zers [13, 14].
With regards to gender, there have been no significant
changes in coverage noted with the addition of pharmacists
as immunizers, however each year there is a significant dif-
ference between more females than males receiving their
influenza vaccination. This could be associated with the
fact that women see their physician more regularly than
men, or visit their pharmacy more often than men to pick
up prescriptions, allowing physicians and pharmacists to
make a recommendation for vaccinations [24]. This differ-
ence was also observed in 2001 by Grabenstein et al., not-
ing that 60 % of patients receiving immunizations from 21
pharmacies in the US were female [25].
Conclusions
The addition of pharmacists as immunizers has resulted
in an increase in influenza vaccine coverage rates in
Isenor et al. Journal of Pharmaceutical Policy and Practice  (2016) 9:32 Page 5 of 6
Nova Scotia, Canada. The impact appears to be greatest
among adults who are 65 years of age or older and was
sustained over the first 2 years in which pharmacists
vaccinated. Future studies should address the impact of
the addition of pharmacists over a longer time period
and explore the potential for targeted interventions by
pharmacists to increase vaccine coverage among other
at-risk populations.
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